Cell based Assay Market: Overview
Cell biology is currently the biggest revenue contributor among all others, to the life-science tools industry, accounting for approximately 30 % of total sales. Cell based assays can range from cytotoxic assays to metabolic assays and cell proliferation. The development of such cell based assays includes high throughput screening assays, which are used to characterize drug stability for GLP GMP lot release. It also aids in checking drug potency and for drug purification, as well as production support. MOA, such as receptor activation, receptor binding, cell signalling, subcellular localization, and drug internalization can be delineated via cell-based assays following treatment via pharmaceuticals.
Cell based assays are utilized exclusively by pharmaceutical companies, biotechnology companies, academic research institutes, contract research organizations, government institutes, and others. Apart from the many possibilities in the future, cell based assays have already proven their usefulness in research of many life-threatening diseases such as cancer and autoimmune diseases.
Cell Based Assay Market: Region-wise Outlook
Based on geography the market is analyzed under the various regions of North America, Latin America, Europe, Asia-Pacific and the Middle-East & Africa. North America is closely followed by Europe in terms of having the biggest market for cell based assays mainly due to the rising drug related research & development activities, along with, increase in adoption of cell based assay platforms and huge number of pharmaceutical and biotechnology companies in this region. Asia Pacific region is once again expected to show high growth rate in the cell based assays market like in most healthcare markets in next few years.
Key Questions Answered
� Among the many uses of cell based assays, which is the most valuable to the current Healthcare market?
� Which product segment must be developed to meet the current demands of drug discovery in the healthcare industry?
� Are the product segments focusing on finding cures for diseases such as cancer and autoimmune diseases getting enough attention in terms of resources dedicated to R & D?
� How will the increase in government spending on healthcare in the rapidly growing countries of APAC affect the global market? � What is the status of the current competitive landscape in the cell based assay market? � Which companies are dominating in the market right now? What is the best market entry strategy to be followed for new entrants?